Population Health Sciences

You are here

Publications

Found 6 results
Author Title [ Type(Desc)] Year
Filters: Keyword is Prospective Studies  [Clear All Filters]
Journal Article
Garrido MM, Prigerson HG, Bao Y, Maciejewski PK.  2016.  Chemotherapy Use in the Months Before Death and Estimated Costs of Care in the Last Week of Life.. J Pain Symptom Manage. 51(5):875-881.e2.
Prigerson HG, Bao Y, Shah MA, M Paulk E, LeBlanc TW, Schneider BJ, Garrido MM, M Reid C, Berlin DA, Adelson KB et al..  2015.  Chemotherapy Use, Performance Status, and Quality of Life at the End of Life.. JAMA Oncol. 1(6):778-84.
Ghomrawi HMK, Mancuso CA, Dunning A, Valle AGonzalez D, Alexiades M, Cornell C, Sculco T, Bostrom M, Mayman D, Marx RG et al..  2017.  Do Surgeon Expectations Predict Clinically Important Improvements in WOMAC Scores After THA and TKA? Clin Orthop Relat Res. 475(9):2150-2158.
Berg AT, Coryell J, Saneto RP, Grinspan ZM, Alexander JJ, Kekis M, Sullivan JE, Wirrell EC, Shellhaas RA, Mytinger JR et al..  2017.  Early-Life Epilepsies and the Emerging Role of Genetic Testing.. JAMA Pediatr. 171(9):863-871.
Demarest ST, Shellhaas RA, Gaillard WD, Keator C, Nickels KC, Hussain SA, Loddenkemper T, Patel AD, Saneto RP, Wirrell E et al..  2017.  The impact of hypsarrhythmia on infantile spasms treatment response: Observational cohort study from the National Infantile Spasms Consortium.. Epilepsia. 58(12):2098-2103.
Knupp KG, Coryell J, Nickels KC, Ryan N, Leister E, Loddenkemper T, Grinspan Z, Hartman AL, Kossoff EH, Gaillard WD et al..  2016.  Response to treatment in a prospective national infantile spasms cohort.. Ann Neurol. 79(3):475-84.